Bandingkan metode
Tinjau metode pilihan Anda berdampingan; baris yang berbeda akan disorot.
| Pencocokan Tepat yang Dikasar untuk Efek Perlakuan Heterogen× | Pencocokan Skor Propensitas× | |
|---|---|---|
| Bidang≠ | Inferensi Kausal | Statistika Penelitian |
| Keluarga≠ | Regression model | Process / pipeline |
| Tahun asal≠ | 2012-2013 | 1983 |
| Pencetus≠ | Iacus, King & Porro (CEM foundation, 2012); subgroup HTE extensions by Imai & colleagues | Paul Rosenbaum and Donald Rubin |
| Tipe≠ | Matching-based causal inference with subgroup CATE estimation | Method |
| Sumber perintis≠ | Iacus, S. M., King, G., & Porro, G. (2012). Causal Inference without Balance Checking: Coarsened Exact Matching. Political Analysis, 20(1), 1-24. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Alias≠ | HTE-CEM, CEM with CATE estimation, subgroup CEM, coarsened exact matching with effect heterogeneity | PSM, propensity score weighting, covariate balance |
| Terkait≠ | 5 | 3 |
| Ringkasan≠ | Heterogeneous treatment effect coarsened exact matching (HTE-CEM) extends the coarsened exact matching framework to estimate how treatment effects vary across subgroups or individual characteristics. After CEM creates balanced strata by coarsening continuous covariates into bins and exactly matching units within each bin, conditional average treatment effects (CATEs) are computed within or across these strata, revealing where treatment works, for whom, and by how much. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateSet data ↗ |
|
|